Eugenio Galli

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 387 citations · Full text

Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma

Raphaël Liévin, Roberta Di Blasi, Florence Morin et al. · Bone Marrow Transplantation · 2022 · 64 citations · Full text

G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma

Eugenio Galli, Vincent Allain, Roberta Di Blasi et al. · Bone Marrow Transplantation · 2020 · 58 citations

Lymphoid Neoplasia, Medicine, Immunology +6

The CD4/CD8 ratio of infused CD19‐CAR‐T is a prognostic factor for efficacy and toxicity

Eugenio Galli, Silvia Bellesi, Ilaria Pansini et al. · British Journal of Haematology · 2023 · 42 citations · Full text

Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with <scp>anti‐CD19 CAR‐T</scp> cells

Eugenio Galli, Federica Sorà, Stefan Hohaus et al. · British Journal of Haematology · 2022 · 41 citations · Full text